Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Lifecore Biomedical, Inc. (LFCR) had Return on Investments of -31.95% for the most recently reported fiscal year, ending 2023-05-31.
| Income Statement Financials | |
$103.27M |
|
$-99.56M |
|
$75.28M |
|
$27.98M |
|
$125.06M |
|
$-21.80M |
|
$-42.13M |
|
$-63.93M |
|
$-63.93M |
|
$-64.24M |
|
$-64.24M |
|
$-99.56M |
|
$-64.24M |
|
$-21.80M |
|
$-7.21M |
|
29.96M |
|
29.96M |
|
$-3.32 |
|
$-3.32 |
|
| Balance Sheet Financials | |
$93.88M |
|
$134.39M |
|
$159.67M |
|
$253.54M |
|
$39.29M |
|
$165.97M |
|
$179.17M |
|
$218.46M |
|
$-4.23M |
|
$17.01M |
|
$35.09M |
|
30.32M |
|
| Cash Flow Statement Financials | |
$-17.44M |
|
$-4.81M |
|
$39.70M |
|
$1.64M |
|
$19.09M |
|
$17.45M |
|
$3.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.39 |
|
-- |
|
-- |
|
0.83 |
|
4.75 |
|
27.10% |
|
-21.11% |
|
-21.11% |
|
-6.98% |
|
-61.90% |
|
-96.41% |
|
$-38.92M |
|
-- |
|
-- |
|
-- |
|
0.41 |
|
1.84 |
|
3.56 |
|
102.58 |
|
1518.58% |
|
-377.70% |
|
-25.34% |
|
|
Return on Investments |
-31.95% |
$1.16 |
|
$-1.30 |
|
$-0.58 |
|